Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven

SUMMARY OBJECTIVE Diabetes is one of the leading causes of cardiovascular mortality. Over the last years, mortality has decreased significantly, more in individuals with diabetes than in healthy ones. That is mostly due to the control of other cardiovascular risk factors. The objective of our study was to analyze the dyslipidemia control in two diabetes cohorts. METHODS Patients from two distinct cohorts were studied, 173 patients from the BHS (Brasília Heart Study) and 222 patients from the BDS (Brazilian Diabetes Study). The data on dyslipidemia control were studied in both different populations. All patients had diabetes. RESULTS There are significant differences concerning comorbidities between the LDL-C and BDS groups. The average glycated hemoglobin is of 8.2 in the LDL-C > 100 group in comparison with 7.7 and 7.5 in the 70-100 and < 70 groups, respectively (p = 0.024). There is a higher percentage of hypertensive patients with LDL between 70-100 (63.9%), when comparing the < 70 and > 100 groups (54.3% and 54.9%, respectively; p = 0.005). Diastolic pressure is higher in the group with LDL > 100, with an average of 87 mmHg, in comparison with 82.6 mmHg and 81.9 mmHg in the 70-100 and < 70 groups, respectively (p = 0.019). The group with LDL > 100 has the greatest percentage of smokers (8.7%) in comparison with the groups with LDL between 70-100 and < 70 (5.6% and 4.3%, respectively; p = 0.015). There is also a difference in the previous incidence of coronaropathy. In the group with LDL < 70, 28.3% of patients had already experienced a previous infarction, compared with 11.1% and 10.6% in the 70-100 and > 100 groups, respectively (p < 0.001). CONCLUSIONS The data in our study have shown that the dyslipidemia control in diabetic patients is inadequate and there is a tendency of direct association between lack of blood glucose control and lack of dyslipidemia control, in addition to the association with other cardiovascular risk factors, such as diastolic hypertension and smoking. This worsened control might be related to the plateau in the descending curve of mortality, and investments in this regard can improve the cardiovascular health in diabetic patients.

Saved in:
Bibliographic Details
Main Authors: Martins,Nestor S., Mello,Daniel S.S., Barreto,Joaquim, Soares,Alexandre A.S., Breder,Ikaro, Cunha,Jessica, Nadruz,Wilson, Coelho Filho,Otavio R., Matos-Souza,José Roberto, Coelho,Otavio R., Munhoz,Daniel B., Silva,José Carlos Quinaglia e, Sposito,Andrei C., Carvalho,Luiz Sergio F
Format: Digital revista
Language:English
Published: Associação Médica Brasileira 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100003
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-42302019000100003
record_format ojs
spelling oai:scielo:S0104-423020190001000032019-02-05Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heavenMartins,Nestor S.Mello,Daniel S.S.Barreto,JoaquimSoares,Alexandre A.S.Breder,IkaroCunha,JessicaNadruz,WilsonCoelho Filho,Otavio R.Matos-Souza,José RobertoCoelho,Otavio R.Munhoz,Daniel B.Silva,José Carlos Quinaglia eSposito,Andrei C.Carvalho,Luiz Sergio F Dyslipidemias Diabetes mellitus Risk factors Targets SUMMARY OBJECTIVE Diabetes is one of the leading causes of cardiovascular mortality. Over the last years, mortality has decreased significantly, more in individuals with diabetes than in healthy ones. That is mostly due to the control of other cardiovascular risk factors. The objective of our study was to analyze the dyslipidemia control in two diabetes cohorts. METHODS Patients from two distinct cohorts were studied, 173 patients from the BHS (Brasília Heart Study) and 222 patients from the BDS (Brazilian Diabetes Study). The data on dyslipidemia control were studied in both different populations. All patients had diabetes. RESULTS There are significant differences concerning comorbidities between the LDL-C and BDS groups. The average glycated hemoglobin is of 8.2 in the LDL-C > 100 group in comparison with 7.7 and 7.5 in the 70-100 and < 70 groups, respectively (p = 0.024). There is a higher percentage of hypertensive patients with LDL between 70-100 (63.9%), when comparing the < 70 and > 100 groups (54.3% and 54.9%, respectively; p = 0.005). Diastolic pressure is higher in the group with LDL > 100, with an average of 87 mmHg, in comparison with 82.6 mmHg and 81.9 mmHg in the 70-100 and < 70 groups, respectively (p = 0.019). The group with LDL > 100 has the greatest percentage of smokers (8.7%) in comparison with the groups with LDL between 70-100 and < 70 (5.6% and 4.3%, respectively; p = 0.015). There is also a difference in the previous incidence of coronaropathy. In the group with LDL < 70, 28.3% of patients had already experienced a previous infarction, compared with 11.1% and 10.6% in the 70-100 and > 100 groups, respectively (p < 0.001). CONCLUSIONS The data in our study have shown that the dyslipidemia control in diabetic patients is inadequate and there is a tendency of direct association between lack of blood glucose control and lack of dyslipidemia control, in addition to the association with other cardiovascular risk factors, such as diastolic hypertension and smoking. This worsened control might be related to the plateau in the descending curve of mortality, and investments in this regard can improve the cardiovascular health in diabetic patients.info:eu-repo/semantics/openAccessAssociação Médica BrasileiraRevista da Associação Médica Brasileira v.65 n.1 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100003en10.1590/1806-9282.65.1.3
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Martins,Nestor S.
Mello,Daniel S.S.
Barreto,Joaquim
Soares,Alexandre A.S.
Breder,Ikaro
Cunha,Jessica
Nadruz,Wilson
Coelho Filho,Otavio R.
Matos-Souza,José Roberto
Coelho,Otavio R.
Munhoz,Daniel B.
Silva,José Carlos Quinaglia e
Sposito,Andrei C.
Carvalho,Luiz Sergio F
spellingShingle Martins,Nestor S.
Mello,Daniel S.S.
Barreto,Joaquim
Soares,Alexandre A.S.
Breder,Ikaro
Cunha,Jessica
Nadruz,Wilson
Coelho Filho,Otavio R.
Matos-Souza,José Roberto
Coelho,Otavio R.
Munhoz,Daniel B.
Silva,José Carlos Quinaglia e
Sposito,Andrei C.
Carvalho,Luiz Sergio F
Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
author_facet Martins,Nestor S.
Mello,Daniel S.S.
Barreto,Joaquim
Soares,Alexandre A.S.
Breder,Ikaro
Cunha,Jessica
Nadruz,Wilson
Coelho Filho,Otavio R.
Matos-Souza,José Roberto
Coelho,Otavio R.
Munhoz,Daniel B.
Silva,José Carlos Quinaglia e
Sposito,Andrei C.
Carvalho,Luiz Sergio F
author_sort Martins,Nestor S.
title Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_short Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_full Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_fullStr Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_full_unstemmed Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
title_sort prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven
description SUMMARY OBJECTIVE Diabetes is one of the leading causes of cardiovascular mortality. Over the last years, mortality has decreased significantly, more in individuals with diabetes than in healthy ones. That is mostly due to the control of other cardiovascular risk factors. The objective of our study was to analyze the dyslipidemia control in two diabetes cohorts. METHODS Patients from two distinct cohorts were studied, 173 patients from the BHS (Brasília Heart Study) and 222 patients from the BDS (Brazilian Diabetes Study). The data on dyslipidemia control were studied in both different populations. All patients had diabetes. RESULTS There are significant differences concerning comorbidities between the LDL-C and BDS groups. The average glycated hemoglobin is of 8.2 in the LDL-C > 100 group in comparison with 7.7 and 7.5 in the 70-100 and < 70 groups, respectively (p = 0.024). There is a higher percentage of hypertensive patients with LDL between 70-100 (63.9%), when comparing the < 70 and > 100 groups (54.3% and 54.9%, respectively; p = 0.005). Diastolic pressure is higher in the group with LDL > 100, with an average of 87 mmHg, in comparison with 82.6 mmHg and 81.9 mmHg in the 70-100 and < 70 groups, respectively (p = 0.019). The group with LDL > 100 has the greatest percentage of smokers (8.7%) in comparison with the groups with LDL between 70-100 and < 70 (5.6% and 4.3%, respectively; p = 0.015). There is also a difference in the previous incidence of coronaropathy. In the group with LDL < 70, 28.3% of patients had already experienced a previous infarction, compared with 11.1% and 10.6% in the 70-100 and > 100 groups, respectively (p < 0.001). CONCLUSIONS The data in our study have shown that the dyslipidemia control in diabetic patients is inadequate and there is a tendency of direct association between lack of blood glucose control and lack of dyslipidemia control, in addition to the association with other cardiovascular risk factors, such as diastolic hypertension and smoking. This worsened control might be related to the plateau in the descending curve of mortality, and investments in this regard can improve the cardiovascular health in diabetic patients.
publisher Associação Médica Brasileira
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100003
work_keys_str_mv AT martinsnestors prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT mellodanielss prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT barretojoaquim prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT soaresalexandreas prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT brederikaro prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT cunhajessica prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT nadruzwilson prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT coelhofilhootavior prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT matossouzajoseroberto prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT coelhootavior prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT munhozdanielb prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT silvajosecarlosquinagliae prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT spositoandreic prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
AT carvalholuizsergiof prevalencetreatmentandcontrolofdyslipidemiaindiabeticparticipantsoftwobraziliancohortsaplacefarfromheaven
_version_ 1756410010664960000